Literature DB >> 29569150

Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder.

Hanan Qasem1, Laila Al-Ayadhi2,3,4, Geir Bjørklund5, Salvatore Chirumbolo6, Afaf El-Ansary7,8,9,10.   

Abstract

Autism spectrum disorder (ASD) is a multifactorial disorder caused by an interaction between environmental risk factors and a genetic background. It is characterized by impairment in communication, social interaction, repetitive behavior, and sensory processing. The etiology of ASD is still not fully understood, and the role of neuroinflammation in autism behaviors needs to be further investigated. The aim of the present study was to test the possible association between prostaglandin E2 (PGE2), cyclooxygenase-2 (COX-2), microsomal prostaglandin E synthase-1 (mPGES-1), prostaglandin PGE2 EP2 receptors and nuclear kappa B (NF-κB) and the severity of cognitive disorders, social impairment, and sensory dysfunction. PGE2, COX-2, mPGES-1, PGE2-EP2 receptors and NF-κB as biochemical parameters related to neuroinflammation were determined in the plasma of 47 Saudi male patients with ASD, categorized as mild to moderate and severe as indicated by the Childhood Autism Rating Scale (CARS) or the Social Responsiveness Scale (SRS) or the Short Sensory Profile (SSP) and compared to 46 neurotypical controls. The data indicated that ASD patients have remarkably higher levels of the measured parameters compared to neurotypical controls, except for EP2 receptors that showed an opposite trend. While the measured parameter did not correlate with the severity of social and cognitive dysfunction, PGE2, COX-2, and mPGES-1 were remarkably associated with the dysfunction in sensory processing. NF-κB was significantly increased in relation to age. Based on the discussed data, the positive correlation between PGE2, COX-2, and mPGES-1 confirm the role of PGE2 pathway and neuroinflammation in the etiology of ASD, and the possibility of using PGE2, COX-2 and mPGES-1 as biomarkers of autism severity. NF-κB as inflammatory inducer showed an elevated level in plasma of ASD individuals. Receiver operating characteristic analysis together with predictiveness diagrams proved that the measured parameters could be used as predictive biomarkers of biochemical correlates to ASD.

Entities:  

Keywords:  Autism; Childhood autism rating scale; Cyclooxygenase-2, microsomal prostaglandin E synthase-1, neuroinflammation; NF-κB: Nuclear factor kappa B, PGE2: prostaglandin E 2, short sensory profile; Social responsiveness scale

Mesh:

Substances:

Year:  2018        PMID: 29569150     DOI: 10.1007/s11011-018-0206-6

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  89 in total

1.  An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia.

Authors:  N Laflamme; S Lacroix; S Rivest
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC): response to genistein and pyrrolidine dithiocarbamate.

Authors:  W Li; J Xia; G Y Sun
Journal:  J Interferon Cytokine Res       Date:  1999-02       Impact factor: 2.607

Review 3.  Cyclooxygenases and the central nervous system.

Authors:  W E Kaufmann; K I Andreasson; P C Isakson; P F Worley
Journal:  Prostaglandins       Date:  1997-09

4.  Microglial activation and chronic neurodegeneration.

Authors:  Melinda E Lull; Michelle L Block
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 5.  The role of eicosanoids in the brain.

Authors:  Daniella Tassoni; Gunveen Kaur; Richard S Weisinger; Andrew J Sinclair
Journal:  Asia Pac J Clin Nutr       Date:  2008       Impact factor: 1.662

6.  Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children.

Authors:  Michael G Chez; Tim Dowling; Pikul B Patel; Pavan Khanna; Matt Kominsky
Journal:  Pediatr Neurol       Date:  2007-06       Impact factor: 3.372

7.  Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.

Authors:  Louise McCullough; Liejun Wu; Norman Haughey; Xibin Liang; Tracey Hand; Qian Wang; Richard M Breyer; Katrin Andreasson
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

8.  Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-κB and AP-1 activation in RAW 264.7 macrophages.

Authors:  Dong-Joo Kwon; Sung Mi Ju; Gi Soo Youn; Soo Young Choi; Jinseu Park
Journal:  Food Chem Toxicol       Date:  2013-05-28       Impact factor: 6.023

9.  The effects of interleukin-6, leukemia inhibitory factor and interferon-gamma on STAT DNA binding and c-fos mRNA levels in cortical astrocytes and C6 glioma cells.

Authors:  Shirzad Jenab; Vanya Quinones-Jenab
Journal:  Neuro Endocrinol Lett       Date:  2002-08       Impact factor: 0.765

10.  Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain.

Authors:  S Rose; S Melnyk; O Pavliv; S Bai; T G Nick; R E Frye; S J James
Journal:  Transl Psychiatry       Date:  2012-07-10       Impact factor: 6.222

View more
  10 in total

Review 1.  The Role of Lipidomics in Autism Spectrum Disorder.

Authors:  Afaf El-Ansary; Salvatore Chirumbolo; Ramesa Shafi Bhat; Maryam Dadar; Eiman M Ibrahim; Geir Bjørklund
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

2.  Altered Metabolic Characteristics in Plasma of Young Boys with Autism Spectrum Disorder.

Authors:  Lei Wang; Ruixuan Zheng; Ying Xu; Ziyun Zhou; Ping Guan; Yanling Wu; Jian Zhou; Zaohuo Cheng; Lili Zhang
Journal:  J Autism Dev Disord       Date:  2021-11-20

Review 3.  Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder.

Authors:  Geir Bjørklund; Nagwa A Meguid; Afaf El-Ansary; Mona A El-Bana; Maryam Dadar; Jan Aaseth; Maha Hemimi; Joško Osredkar; Salvatore Chirumbolo
Journal:  J Mol Neurosci       Date:  2018-10-24       Impact factor: 3.444

Review 4.  Environmental influence on neurodevelopmental disorders: Potential association of heavy metal exposure and autism.

Authors:  Omamuyovwi M Ijomone; Nzube F Olung; Grace T Akingbade; Comfort O A Okoh; Michael Aschner
Journal:  J Trace Elem Med Biol       Date:  2020-08-29       Impact factor: 3.849

5.  Perturbed MAPK signaling in ASD: Impact of metal neurotoxicity.

Authors:  Oritoke M Aluko; Saheed A Lawal; Omamuyovwi M Ijomone; Michael Aschner
Journal:  Curr Opin Toxicol       Date:  2021-04-02

6.  Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder.

Authors:  P M Abruzzo; A Matté; A Bolotta; E Federti; A Ghezzo; T Guarnieri; M Marini; A Posar; A Siciliano; L De Franceschi; P Visconti
Journal:  J Transl Med       Date:  2019-10-02       Impact factor: 5.531

Review 7.  Prostanoid Metabolites as Biomarkers in Human Disease.

Authors:  Helena Idborg; Sven-Christian Pawelzik
Journal:  Metabolites       Date:  2022-08-04

8.  Oxidized cell-free DNA as a stress-signaling factor activating the chronic inflammatory process in patients with autism spectrum disorders.

Authors:  Galina V Shmarina; Elizaveta S Ershova; Natalia V Simashkova; Svetlana G Nikitina; Julia M Chudakova; Natalia N Veiko; Lev N Porokhovnik; Anna Y Basova; Antonina F Shaposhnikova; Daria A Pukhalskaya; Vladimir M Pisarev; Natalia J Korovina; Natalia L Gorbachevskaya; Olga A Dolgikh; Marina Bogush; Sergey I Kutsev; Svetlana V Kostyuk
Journal:  J Neuroinflammation       Date:  2020-07-16       Impact factor: 8.322

Review 9.  The Role of Cholesterol and Fatty Acids in the Etiology and Diagnosis of Autism Spectrum Disorders.

Authors:  Cecilia Maria Esposito; Massimiliano Buoli; Valentina Ciappolino; Carlo Agostoni; Paolo Brambilla
Journal:  Int J Mol Sci       Date:  2021-03-29       Impact factor: 5.923

10.  CTRP3 as a novel biomarker in the plasma of Saudi children with autism.

Authors:  Manan Alhakbany; Afaf El-Ansary; Laila Al-Ayadhi
Journal:  PeerJ       Date:  2022-01-11       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.